Product Information
CLINDAMYCIN (PEDI) 75 MG/5 ML is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.1288 per ML under NDC 53746046819. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Mar 13, 2014.
Strength
75 mg/5mL
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746046819
Classification
Generic
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN PALMITATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203513FDA Approved
3/13/2014
On Market Since
4/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has been published 82 times since Mar 12, 2025, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1288 per ML |
|---|---|
| All-time high | $0.1817 (Sep 10, 2025) |
| All-time low | $0.1274 (Jul 22, 2026) |
| 52-week high | $0.1693 |
| 52-week low | $0.1274 |
| Median price | $0.1517 |
| Average price | $0.1545 |
| Largest weekly change | -6.8% (Sep 17, 2025) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Palmitate Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN (PEDI) 75 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN (PEDI) 75 MG/5 ML, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.1288 per ML (NDC 53746046819), effective Sep 30, 2026.
How has the price of CLINDAMYCIN (PEDI) 75 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has declined 27.5%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN (PEDI) 75 MG/5 ML?
Since Mar 12, 2025, the NADAC for CLINDAMYCIN (PEDI) 75 MG/5 ML has ranged from a low of $0.1274 (Jul 22, 2026) to a high of $0.1817 (Sep 10, 2025), with a median of $0.1517 per ML.
Are there cheaper alternatives to CLINDAMYCIN (PEDI) 75 MG/5 ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN (PEDI) 75 MG/5 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN (PEDI) 75 MG/5 ML?
CLINDAMYCIN (PEDI) 75 MG/5 ML (NDC 53746046819) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.